European Real World Evidence
Accelerate insights.
Scale your therapeutics.

Innovation in life sciences requires fast, secure, and compliant access to high-quality data from real world settings. In Europe, most health data remains locked in silos, inaccessible across borders, and unharmonized.

Tune Insight enables life-science organisations to access, analyze, and collaborate on these European Real World Data sets – without ever moving the data. Our purpose? To accelerate therapeutic development by enabling quick feasibility studies, clinical insights, and real world evidence while guaranteeing full data sovereignty for the data providers.

They trust us

The Data Access Paradox in Pharma

97% hospital data unused.

According to the World Health Organization, most health data remains unused, and about 85% isn’t standardised.

Tune Insight solves these challenges by enabling collaboration without compromising privacy or compliance.

Fragmented and heterogeneous datasets
Limited access to EU5 hospital and registry data
Complex data governance and compliance (GDPR, EHDS)
Long timelines for access to data to run feasibility, and more complex RWE studeis.

Tune Insight in your drug development pipeline

Pre Feasibility

Understand where your patient population exists.

Feasibility Study

Cohort exploration across multiple centres and between countries. Rapid query without data transfers

Clinical Development (Phase I–III)

Develop federated analytics across European affiliates, research centres, and CROs.

Regulatory and Market Access

Provide fast, robust, multi-country Real-World Evidence to support HTA and payer negotiations.

Post-Approval

Continuous evidence generation across distributed RWD sources.

Our manifesto

Tune Insight Solutions for Life Sciences

Run Feasibility across sites

Through our hospital networks, you can run feasibility queries on country representative:
- Patients characteristics
- Overall Survival
- Biomarkers of interest

Real-World Evidence generation

Accelerate HEOR, Market Access and post-approval studies with:
- Harmonised European RWE
- Local execution of analyses (OS, PFS, treatment patterns)
- Fast feasibility assessment
- Fully GDPR and EHDS-ready governance

Federated health data platform for Pharma

Unify R&D, clinical, real-world and commercial data across:
- Countries
- Therapeutic areas
- Affiliates & partners

AI-Powered structuring and exploration

Leverage AI to:
- Harmonise datasets
- Map medical terminologies
- Build cohorts automatically
- Run Python workflows securely

Therapeutic Area Expertise

Our technologies power secure collaboration across Europe.

Oncology
(mNSCLC, pediatric cancer, melanoma, hematology…)
Neurology
(Alzheimer, MS, epilepsy)
Rare Diseases
(metabolic, genetic)
Dermatology & imaging
Cardiovascular
Oncology
(mNSCLC, pediatric cancer, melanoma, hematology…)
Neurology
(Alzheimer, MS, epilepsy)
Rare Diseases
(metabolic, genetic)
Dermatology & imaging
Cardiovascular

Enable your organisation with RWE,
speak to our experts

Tune Insight enables secure, compliant access to European RWE and advanced analytics – accelerating therapeutic development and evidence generation.

Ready to turn your data ecosystem into a strategic asset? Let’s define the next frontier.

European Real World Evidence Accelerate insights. Scale your therapeutics.